ABSTRACT
High serum fatty acid (FA) levels are causally linked to the development of insulin resistance, which eventually progresses to type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) generalized in the term metabolic syndrome. Adipose triglyceride lipase (ATGL) is the initial enzyme in the hydrolysis of intracellular triacylglycerol (TG) stores, liberating fatty acids that are released from adipocytes into the circulation. Hence, ATGL-specific inhibitors have the potential to lower circulating FA concentrations, and counteract the development of insulin resistance and NAFLD. In this article, we report about structure-activity relationship (SAR) studies of small molecule inhibitors of murine ATGL which led to the development of Atglistatin. Atglistatin is a specific inhibitor of murine ATGL, which has proven useful for the validation of ATGL as a potential drug target.
Subject(s)
Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Lipase/antagonists & inhibitors , Phenylurea Compounds/chemistry , Phenylurea Compounds/pharmacology , Animals , Drug Discovery , Lipase/chemistry , Lipase/metabolism , Lipolysis/drug effects , Mice , Structure-Activity Relationship , Triglycerides/bloodABSTRACT
Chiral dienes are useful ligands in a number of asymmetric transition-metal-catalyzed reactions. Here, we evaluate the efficiency of 2,5-disubstituted 1,3a,4,6a-tetrahydropentalenes as ligands to rhodium(I). 2,5-Dibenzyl and diphenyl tetrahydropentalenes were synthesized in two steps and resolved, either chromatographically, or through fractional crystallization of diastereomeric rhodium(I) salts. When evaluated in a 1,4-arylation reaction, the 2,5-dibenzyl ligand gave up to 99% ee. The use of a well-defined rhodium complex as catalyst, Cs2CO3 as the base, and toluene/water as solvent was found to have a pronounced beneficial effect on the selectivity of the reaction. The homologous 2,5-diphenyl ligand on the other hand proved to be highly prone to racemization/loss of chirality during catalysis. Control experiments reveal that this rearrangement proceeds via a rhodium-mediated 1,3-hydride shift. Implications for ligand design and catalysis are discussed.
ABSTRACT
Planar chiral 5,11-disubstiuted dibenzo[a,e]cyclo-octatetraenes (dbCOTs) have been developed as the first useful chiral homologs to dbCOT-ligands for asymmetric applications. Methods enabling the preparation of such compounds on a gram-scale in enantiomerically pure form are described. Evaluated as ligands in rhodium(I)-catalyzed 1,4- and 1,2-arylation reactions, tertiary and quarternary stereogenic centers were formed with excellent yields and selectivities of up to >99 % ee. A catalytic asymmetric synthesis of a key cyclization precursor to (-)-penifulvinâ A highlights the system in an applied context.
ABSTRACT
Adipose triglyceride lipase (ATGL) catalyzes the degradation of cellular triacylglycerol stores and strongly determines the concentration of circulating fatty acids (FAs). High serum FA levels are causally linked to the development of insulin resistance and impaired glucose tolerance, which eventually progresses to overt type 2 diabetes. ATGL-specific inhibitors could be used to lower circulating FAs, which can counteract the development of insulin resistance. In this article, we report about structure-activity relationship (SAR) studies of small molecule inhibitors of ATGL based on a hydrazone chemotype. The SAR indicated that the binding pocket of ATGL requests rather linear compounds without bulky substituents. The best inhibitor showed an IC50=10µM in an assay with COS7-cell lysate overexpressing murine ATGL.
Subject(s)
Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Hydrazones/chemistry , Hydrazones/pharmacology , Lipase/antagonists & inhibitors , Animals , COS Cells , Chlorocebus aethiops , Enzyme Inhibitors/chemical synthesis , Hydrazones/chemical synthesis , Lipase/metabolism , Lipid Metabolism/drug effects , Mice , Small Molecule Libraries/chemical synthesis , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology , Structure-Activity Relationship , Triglycerides/metabolismABSTRACT
Third-row transition metal catalysts remain a largely untapped resource in cycloaddition reactions for the formation of medium-sized rings. Herein, we report the first examples of iridium-catalyzed inter- and intramolecular vinylcyclopropane (VCP)-alkyne (5+2) cycloadditions. DFT modeling suggests that catalysis by iridium(I) proceeds through a mechanism similar to that previously reported for rhodium(I)-catalyzed VCP-alkyne cycloadditions, but a smaller free energy span for iridium enables substantially faster catalysis under favorable conditions. The system is characterized by up to quantitative yields and is amenable to an array of disubstituted alkynes and vinylcyclopropanes.
